Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term outcome for Down syndrome patients with hematopoietic disorders.

Journal of the Formosan Medical Association = Taiwan yi zhi - 1 Feb 2016

Li Meng-Ju, Lee Ni-Chung, Yang Yung-Li, Yen Hsiu-Ju, Chang Hsiu-Hao, Chien Yin-Hsiu, Lu Meng-Yao, Jou Shiann-Tarng, Lin Kai-Hsin, Hwu Wuh-Liang, Lin Dong-Tsamn

Abstract excerpt

BACKGROUND/PURPOSE: Although Down syndrome (DS) patients have a higher risk of developing transient myeloproliferative disorder (TMD) and acute leukemia, very little data is available on long-term outcome in Taiwanese patients. The current study was designed to determine the clinical characteristics and treatment outcome of DS patients with TMD or acute leukemia (AL). METHODS: In 25 consecutive DS patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Down Syndrome
Share to Drug Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to GATA1 Transcription Factor

Share to Kaplan-Meier Estimate

Share to Leukemia, Myeloid, Acute

Share to Survival Rate

Share to Taiwan

Source

Identifiers

PMID: 26234152
DOI: 10.1016/j.jfma.2015.01.009

Genes

GATA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term outcome for Down syndrome patients with hematopoietic disorders.PMID 26234152Read ↗

Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.Semantic proximity Read ↗

Hematological disorders in children with Down syndrome.Semantic proximity Read ↗

Clinical and biological aspects of myeloid leukemia in Down syndrome.Semantic proximity Read ↗

Distinctive hematological abnormalities in East Asian neonates and children with Down syndrome.Semantic proximity Read ↗

Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international studySemantic proximity Read ↗

Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndromeSemantic proximity Read ↗

Down syndrome and leukemia: insights into leukemogenesis and translational targets.Semantic proximity Read ↗

Myeloid Proliferations Associated with Down Syndrome: Clinicopathologic Characteristics of Forty Cases from Five Large Academic Institutions.Semantic proximity Read ↗

Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndrome.Semantic proximity Read ↗

Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.Semantic proximity Read ↗

Mutations of GATA1, FLT3, MLL-partial tandem duplication, NRAS, and RUNX1 genes are not found in a 7-year-old Down syndrome patient with acute myeloid leukemia (FAB-M2) having a good prognosis.Semantic proximity Read ↗

Recent advances in the understanding of transient abnormal myelopoiesis in Down syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.